Kiniksa Pharmaceutic...
NasdaqGS:KNSA
$ 45,85
+ $0,91 (2,02%)
45,85 $
+$0,91 (2,02%)
End-of-day quote: 03/25/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$0,75
Earnings Per Share
$8,85
Revenue Per Share
54,66%
Gross Margin %
$3,51 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$0,75
Revenue Per Share
$8,85
Gross Margin %
54,66%
Market Cap
$3,51 B
Long-Term Debt
$0,00 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017
EPS Earnings Per Share $0,75 $-0,60 $0,20 $2,60 $-2,29 $-2,61 $-2,99 $-3,49 $-2,73
Earnings Earnings $57,41M $-43,58M $14,12M $181,35M $-158,24M $-178,08M $-166,09M $-189,61M $-11,71M
RPS Revenue Per Share $0,00 $8,85 $5,83 $3,83 $3,16 $0,56 $0,00 $0,00 $0,00 $0,00
Revenue Revenue $0,00M $677,56M $423,24M $270,26M $220,18M $38,54M $0,00M $0,00M $0,00M $0,00M
OCF Operating Cash Flow $0,00M $69,00M $25,69M $13,30M $5,81M $-126,30M $-136,53M $-158,37M $-81,01M $0,00M
FCF Free Cash Flow $0,00M $67,33M $25,41M $-11,00M $5,70M $-126,71M $-136,82M $-161,57M $-86,30M $0,00M
OM Operating Margin 0,00% 11,40% -10,78% -9,32% 4,44% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 54,66% 55,29% 66,72% 78,67% 74,22% 0,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $0,00 $1,84 $0,36 $0,19 $0,08 $-2,14 $-2,21 $-2,99 $-2,92 $-27,79
LT Debt Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 76,54M 76,54M 72,64M 70,62M 69,75M 69,1M 68,23M 55,55M 54,33M 4,29M
×